Tagiamon, Demetrio .

HRN: 21-40-06  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/21/2022
05/27/2022
IV
4.5
Q8
Necrotizing Fascitis
Waiting Final Action 
05/21/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/21/2022
05/27/2022
IV
600mg
Q8
Necrotizing Fascitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: